Journal
HELIYON
Volume 7, Issue 8, Pages -Publisher
CELL PRESS
DOI: 10.1016/j.heliyon.2021.e07710
Keywords
Antileishmanial; Actinomycetes; Marine-resources; Metagenomic; Drug discovery
Categories
Funding
- Universitas Airlangga
Ask authors/readers for more resources
The increasing drug resistance has led to a renewed interest in natural products, particularly in unexplored marine environments. Research efforts are now focused on discovering new compounds from the marine ecosystem to combat drug resistance.
Revived analysis interests in natural products in the hope of discovering new and novel antileishmanial drug leads have been driven partially by the increasing incidence of drug resistance. However, the search for novel che-motherapeutics to combat drug resistance had previously concentrated on the terrestrial environment. As a result, the marine environment was of ten overlooked. For example, actinomycetes are an immensely important group of bacteria for antibiotic production, producing two-thirds of the known antibiotics. However, these bacteria have been isolated primarily from terrestrial sources. Consequently, there have been revived efforts to discover new compounds from uncharted or uncommon environments like the marine ecosystem. Isolation, purification and structure elucidation of target compounds from complex metabolic extract are major challenges in natural products chemistry. As a result, marine-derived natural products from actinomycetes that have antileishmanial bioactivity potentials have been understudied. This review highlights metagenomic and bioassay approaches which could help streamline the drug discovery process thereby greatly reducing time and cost of dereplication to identify suitable antileishmanial drug candidates.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available